St. Teresa Medical

About:

St. Teresa Medical is a medical applications developing company commercializing a hemostatic technology platform called FASTCLOT.

Website: http://stteresamedical.com

Description:

St. Teresa Medical, Inc. is a medical device company commercializing a new hemostatic technology platform called FASTCLOT®. Dressings currently used to treat moderate and severe bleeding injuries caused by surgery, traumatic accidents or violence have limited clotting capabilities. The patent-pending FASTCLOT® technology: (a) accelerates the clotting cascade by adding robust clot-forming proteins to an injury site, stopping bleeding faster and potentially saving lives; and (b) is the only fibrin-based clotting dressing with a rapidly dissolvable and absorbable delivery mechanism.

Total Funding Amount:

$11.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Saint Paul, Minnesota, United States

Founded Date:

2010-01-01

Founders:

Brian Jackson, Phil Messina

Number of Employees:

1-10

Last Funding Date:

2019-08-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai